Literature DB >> 908876

Relationship of levels of circulating immune complexes to histologic patterns of nephritis: a comparative study of membranous glomerulonephropathy and diffuse proliferative glomerulonephritis.

Y M Ooi, B S Ooi, V E Pollak.   

Abstract

Immunofluorescent studies have suggested that immune complex deposition is the pathogenetic mechanism responsible for MGN and diffuse PGN. Despite this common mechanism, both renal disorders show considerable differences in the rate of progression of renal functional deterioration. To examine whether differences in the amounts of circulating immune complexes may in part be responsible for these differences, such complexes were assayed for in the sera of the two patient populations by a 1251-C1q binding assay, which has a lower limit of sensitivity for 75 microgram of aggregated human gamma globulin per milliliter of serum. Circulating complexes were found in sera from 11 of 14 patients with diffuse PGN but were undetectable in sera from 13 patients with MGN. Additional evidence for existing differences in the amounts of circulating immune complexes in the two groups was provided by serum C3 measurements. Serum C3 concentrations were below normal limits in nine of 14 sera from patients with diffuse PGN but were within normal limits for sera from all patients with MGN. Sucrose density gradient ultracentrifugation analysis of C1q reactive complexes showed them to have sedimentation coefficients ranging from 14.6S to 18.2S. The sizes of the complexes are consistent with those analyzed in animal models as being capable of inducing nephritis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 908876

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  11 in total

1.  Long-term effects of steroid and cytostatic treatment on the clinical course of idiopathic membranous glomerulonephritis (retrospective study).

Authors:  G Mohácsi; A Magori; S Sonkodi
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

Review 2.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

3.  Immune complexes: biochemical and biological aspects.

Authors:  P Seth
Journal:  Indian J Pediatr       Date:  1983 Sep-Oct       Impact factor: 1.967

4.  Serial studies on circulating immune complexes in post-streptococcal sequelae.

Authors:  I van de Rijn; H Fillit; W E Brandeis; H Reid; T Poon-King; M McCarthy; N K Day; J B Zabriskie
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

5.  Application of the solid phase C1q and Raji cell radioimmune assays for the detection of circulating immune complexes in glomerulonephritis.

Authors:  K S Tung; A J Woodroffe; T D Ahlin; R C Williams; C B Wilson
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

6.  Circulating and deposited immune complexes in patients with glomerular disease: immunopathologic correlations.

Authors:  I Stachura; T L Whiteside; R H Kelly
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

7.  Experimental glomerulonephritis in the isolated perfused rat kidney.

Authors:  W G Couser; D R Steinmuller; M M Stilmant; D J Salant; L M Lowenstein
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

8.  Diminished synthesis of immunoglobulin by peripheral lymphocytes of patients with idiopathic membranous glomerulonephropathy.

Authors:  B S Ooi; Y M Ooi; A Hsu; P E Hurtubise
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

9.  Study of circulating immune complex size in systemic lupus erythematosus.

Authors:  K S Tung; R J DeHoratius; R C Williams
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

10.  Detection of DNA-bound immunoglobulins in patients with lupus nephritis, using monoclonal anti-DNA antibody.

Authors:  A Koyama; M Kobayashi; S Suzuki; M Suzuki; N Yamaguchi; M Narita
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.